Accolade Inc
NASDAQ:ACCD

Watchlist Manager
Accolade Inc Logo
Accolade Inc
NASDAQ:ACCD
Watchlist
Price: 7.02 USD Market Closed
Market Cap: $575.6m

Accolade Inc
Cash Equivalents

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Accolade Inc
Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Accolade Inc
NASDAQ:ACCD
Cash Equivalents
$185.9m
CAGR 3-Years
-20%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Quest Diagnostics Inc
NYSE:DGX
Cash Equivalents
$393m
CAGR 3-Years
31%
CAGR 5-Years
-20%
CAGR 10-Years
12%
CVS Health Corp
NYSE:CVS
Cash Equivalents
$8.5B
CAGR 3-Years
-13%
CAGR 5-Years
1%
CAGR 10-Years
13%
Cigna Corp
NYSE:CI
Cash Equivalents
$7.7B
CAGR 3-Years
9%
CAGR 5-Years
-5%
CAGR 10-Years
15%
Laboratory Corporation of America Holdings
NYSE:LH
Cash Equivalents
$532.3m
CAGR 3-Years
7%
CAGR 5-Years
-17%
CAGR 10-Years
-3%
Guardant Health Inc
NASDAQ:GH
Cash Equivalents
$378.2m
CAGR 3-Years
39%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
No Stocks Found

Accolade Inc
Glance View

Accolade, Inc. engages in the provision of personalized health and benefits solutions. The company is headquartered in Seattle, Washington and currently employs 2,350 full-time employees. The company went IPO on 2020-07-02. The Company’s customers are primarily employers that deploy Accolade in order to provide employees and their families members a single place to turn for their health, healthcare, and benefits needs. Its platform combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. The firm leverages its integrated capabilities, connectivity with providers and the healthcare ecosystem, and longitudinal data to engage across the member population. Its offerings are: Accolade Total Benefits, Accolade Total Care, Accolade Total Health and Benefits, Accolade Boost, the Trusted Supplier Program, and Mental Health Integrated Care solutions.

ACCD Intrinsic Value
8.24 USD
Undervaluation 15%
Intrinsic Value
Price $7.02

See Also

What is Accolade Inc's Cash Equivalents?
Cash Equivalents
185.9m USD

Based on the financial report for Nov 30, 2024, Accolade Inc's Cash Equivalents amounts to 185.9m USD.

What is Accolade Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 3Y
-20%

Over the last year, the Cash Equivalents growth was -19%. The average annual Cash Equivalents growth rates for Accolade Inc have been -20% over the past three years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett